Company & Sponsor Intelligence

Universitätsklinikum Hamburg-Eppendorf

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials8

Recruiting1

Completed3

Countries1

Therapeutic footprint

autismdepressionmultiple_sclerosisother_psychiatrystrokesubstance_use

Indexed studies

NCT04236544Patient Experiences of Multiple Sclerosis (PExMS)
multiple_sclerosis · NA

NCT04054336The Approach and Avoidance Task (AAT) in Alcoholic Inpatients
substance_use · GermanyNA

NCT03333239Short-term, Long-term and Cost-effectiveness of Treating Depression and Anxiety Disorders in Children and Adolescents
depression · NA

NCT06502054Parenting with an Autism Spectrum Disorder
autism · GermanyRECRUITING

NCT06809959Bifocal Transcranial Alternating Current Stimulation Targeting the Frontoparietal Network in Stroke Patients
stroke · GermanyNA

NCT03795948Patient Reported Outcomes in Stroke Care
stroke · GermanyNA

NCT03872648TransCare - Genital Surgery for Trans Women in Centralized vs. Decentralized Health Care Delivery Settings
other_psychiatry · GermanyUNKNOWN

NCT01770990Trial of Telephone-based Psychotherapy for Depression With and Without Adjunctive Supportive Mail
depression · GermanyNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →